- Research article
- Open Access
Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation
BMC Immunology volume 15, Article number: 6 (2014)
Vitamin D receptor (VDR) deficiency contributes to the development of experimental inflammatory bowel disease (IBD) in several different models. T cells have been shown to express the VDR, and T cells are targets of vitamin D. In this article we determined the effects of VDR expression on CD8+ T cells.
VDR KO CD8+ T cells, but not WT CD8+ T cells, induced colitis in Rag KO recipients. In addition, co-transfer of VDR KO CD8+ T cells with naïve CD4+ T cells accelerated colitis development. The more severe colitis was associated with rapidly proliferating naïve VDR KO CD8+ T cells and increased IFN-γ and IL-17 in the gut. VDR KO CD8+ T cells proliferated in vitro without antigen stimulation and did not downregulate CD62L and upregulate CD44 markers following proliferation that normally occurred in WT CD8+ T cells. The increased proliferation of VDR KO CD8+ cells was due in part to the higher production and response of the VDR KO cells to IL-2.
Our data indicate that expression of the VDR is required to prevent replication of quiescent CD8+ T cells. The inability to signal through the VDR resulted in the generation of pathogenic CD8+ T cells from rapidly proliferating cells that contributed to the development of IBD.
Inflammatory bowel diseases (IBD) are immune mediated diseases that result because of a complex interaction between genetics and the environment. Over 3.6 million people in the US and Europe suffer from IBD. Environmental factors that contribute to IBD development include the composition of the normal bacterial flora  and perhaps vitamin D. A major source of vitamin D results from its manufacture via a photolysis reaction in the skin and vitamin D available from sunlight exposure is significantly less in northern climates, and especially low during the winter . In addition dietary intake of vitamin D is problematic since there are few foods, which are naturally rich in vitamin D. There is evidence for a link between vitamin D availability and the prevalence of immune mediated diseases in general and IBD in particular [3, 4]. In addition, experimental models of IBD are more severe in vitamin D receptor (VDR) KO and vitamin D deficient models . Vitamin D is likely an environmental factor that affects the development of IBD.
T cells have been shown to express the VDR, and T cells are both direct and indirect targets of vitamin D. In addition, the active form of vitamin D (1,25(OH)2D3) suppressed the development of experimental models of T cell mediated diseases including IBD, multiple sclerosis and type-1 diabetes [6, 7]. Conversely, vitamin D deficiency and/or VDR deficiency resulted in an exacerbation of experimental IBD . Expression of the VDR does not affect the development of normal numbers of CD4 and CD8αβ T cells in the thymus or in the periphery [5, 8, 9]. VDR KO CD4+ T cells express more IL-17, and IFN-γ, proliferate more rapidly in a mixed lymphocyte reaction and induce more severe colitis than WT CD4 cells [5, 10]. Mice with VDR specific KO in T cells have increased incidence of experimental autoimmune encephalomyelitis and VDR expression in T cells was shown to be essential for the effectiveness of 1,25(OH)2D3 for the suppression of disease . 1,25(OH)2D3in vitro suppressed the proliferation of both CD4+ and CD8+ T cells and inhibited the production of IFN-γ, and IL-2 [12, 13]. Vitamin D is required for the development of two regulatory cell populations: NKT cells and CD8αα expressing T cells [9, 14]. In addition, 1,25(OH)2D3 induces CD4+ T regulatory cells in vitro and in vivo[15, 16]. Resting and activated CD8+ T cells have been shown to express higher levels of the VDR than CD4+ T cells; however, the physiological role of vitamin D and the VDR in regulating CD8+ T cell function has not been examined .
CD8+ T cells can be pathogenic, protective or tolerogenic. Pathogenic and protective CD8+ T cells share common features including IFN-γ and TNF-α production as well as cytotoxicity [18, 19]. A pathogenic role for CD8+ T cells has been shown for IBD . Heat shock protein-specific CD8+ T cells transferred severe symptoms of IBD in immunodeficient mice due to the production of IFN-γ and TNF-α . Conversely, several CD8+ T cell subsets have been shown to act in a suppressive or regulatory manner. CD8+ T cells that do not express CD28 (CD8/CD28−), but produced IL-10 in human peripheral blood, suppressed cytotoxic activity and proliferation in vitro. In mice, IL-10 and TGF-β producing CD8/CD28− regulatory T cells inhibited experimental IBD development in the T cell transfer model of IBD . Human CD8/CXCR3+ cells are a second population of human regulatory CD8+ T cells . Like the CD8/CD28− T cells, the mouse homologs of the human CD8/CXCR3+ T cells (CD8/CD122+) suppressed the development of T cell-transfer colitis via the production of IL-10 . Lastly, CD8αα+TCRαβ+ cells found in the intraepithelial lymphocytes (IEL) of the small intestine (SI) have IL-10 mediated regulatory abilities and can suppress development of T cell-transfer colitis [24, 25]. In experimental IBD CD8+ T cells can either cause or protect from disease development.
Here we determined the effects of vitamin D on CD8αβ+ T cells. VDR KO mice had increased numbers of naïve CD8+ T cells that when purified and then transferred to Rag KO recipients induced colitis as determined by histological staining. In addition, co-transfer of VDR KO CD8+ T cells with naïve WT CD4+ cells accelerated the development of colitis in Rag KO recipients. The cause of the VDR KO CD8+ T cell pathogenicity was due to the uncontrolled proliferation of CD8+ T cells in general and naïve CD8+ T cells in particular. In addition, VDR KO CD8+ T cells overproduced IL-2. The rapidly dividing VDR KO CD8+ T cells accumulated in the gut where they induced IFN-γ and IL-17 production.
WT, VDR KO, IL-10 KO, IL-10/VDR double (D) KO and Rag KO mice all on the C57BL/6 background were bred in the animal facilities at the Pennsylvania State University (University Park, PA). The original VDR KO breeders were a gift from Dr. Marie Demay (Harvard University, Boston MA) and the DKO mice were generated as previously described . All other breeders were originally from Jackson Laboratories (Bar Harbor, ME). Experimental procedures were approved by the Office of Research Protection Institutional Animal Care and Use Committee at the Pennsylvania State University.
T cell isolation
CD4+ or CD8+ T cells were purified from the spleen using the mouse CD4+ or CD8+ Recovery Column kit and the manufacturer’s instructions (Cedarlane, Burlington, NC). Column purification was followed by cell sorting (Cytopeia Influx, Seattle, WA) of CD4+, CD8+, CD4+CD45RBhigh, CD8+CD28+/-, CD8+CD122+ T cell subsets. Post-sorting analysis confirmed that the purity of the T cells was >99% (Additional file 1: Figure S1A). IELs were isolated for analyses by removing the Peyer’s patches and splitting the SI lengthwise followed by cutting the SI into 0.5 cm pieces. The pieces were incubated twice in HBSS containing 0.15 μg/ml dithiothreitol and 5%FBS (Sigma-Aldrich, St. Louis, MO) for 20 min at 37°C under 200 rpm rotation. The IEL were collected from the interface of 40/80% Percoll gradients (Sigma-Aldrich).
All transfers used T cells from the spleens of the donor mice. Groups of Rag KO mice were injected intraperitoneally (i.p.) with 1 × 106 CD8+ cells or CD8 T cell sorted subsets (CD28−, CD28+ or CD122+) from WT, VDR KO, IL-10 KO or IL-10/VDR DKO mice. Sorting purity and gating strategies are in Additional file 1: Figure S1. For the co-transfer experiments, Rag KO mice were injected i.p. with 1 × 106 WT or VDR KO (CD45.2+) CD8+ T cells on day -1 and 4 × 105 WT (CD45.1+) CD4+CD45RBhigh cells on day 0. Both CD8 and CD4+CD45RBhigh cells were resuspended in 200 μL PBS. The Rag KO recipients were weighed weekly and euthanized after 7 or 8 wks.
Colitis symptoms measured included: weight loss, colon/body weight (BW) ratios, histopathology scores, diarrhea, rectal bleeding, and rectal prolapse exactly as described . 1 cm of the distal colon was fixed in formalin and sent to the Penn State University Animal Diagnostic Laboratories (University Park, PA) for sectioning and haematoxylin & eosin (H&E) staining. Inflammation and epithelial injury of the colons were scored blindly by two individuals for inflammation (0-4) and epithelial hyperplasia (0-4) . Total histopathology scores ranged from 0-8.
BrdU incorporation assay
Rag KO mice were injected i.p. with 50 μl of 25 mg/ml BrdU dissolved in PBS every two days. The mice were euthanized at d3, d8 and d14 and the MLN and IEL were fixed with ice-cold 95% ethanol and paraformaldehyde digested with DNaseI solution (Sigma).
Cells were stained with: FITC anti-CD8α, FITC anti-CD8β, FITC anti-CD45RB, PE anti-CD45.1, PE anti-CD28, PE anti-CD122, PE anti-CD4, PE anti-CD44, PE anti-CD25, PE-Texas Red (ECD) anti-CD4, PECy5 anti-CD62L, PECy5 anti-TCRβ and PECy7 anti-CD8α (BD Pharmingen, San Jose, CA) for surface markers. Gating strategies for FACS analysis are shown in Additional file 2: Figure S2. For BrdU incorporation assays, cells were stained with Biotin anti-BrdU, FITC streptavidin and Biotin Mouse IgG1, κ isotype control (Biolegend, San Diego, CA). For intracellular cytokine staining, IEL were stimulated with PMA (0.1 μg/ml, Sigma), ionomycin (0.5 μg/ml, Sigma) and Brefeldin A (10 μg/ml, Sigma) for 6 h, fixed with 4% paraformadehyde (Sigma-Aldrich), permeabilized with 0.1% saponin (Sigma-Aldrich), and stained with FITC anti-IFNγ, PE anti-IL-17A, or the FITC/PE labeled Rat IgG1 isotype controls (BD Pharmingen). Flow cytometry was done on a FC500 bench top cytometer (Beckman Coulter, Brea, CA) and the data was analyzed with FlowJo 7.6.5 software (TreeStar, Ashland, OR).
Cell culture and CFSE staining
Purified CD8+ T cells were labeled with CFSE using Cell TRave CFSE Cell Proliferation Kit (Life Technologies, Grand Island, NY). The labeled CD8+ T cells (2 × 106 cells/ml) were cultured with plate bound anti-CD3 (5 μg/ml) and anti-CD28 (5 μg/ml, BD Pharmingen) or 0.2 μg/ml recombinant IL-2 with/without neutralizing IL-2 antibodies (50 ng/ml, Clone: S4B6, BD Pharmingen). Supernatants were collected from 3d cultures of unstimulated or CD3/CD28 stimulated CD8+ T cells, and IL-2 in the supernatant was evaluated using an ELISA kit and the manufacturer’s instructions (BD Pharmingen).
Quantitative real-time PCR
Total RNA was isolated from SI and colon of mice following the manufacturer’s instructions (Qiagen, Valencia, CA). cDNA was synthesized by using the TaqMan reverse transcription reagents kit (Applied Biosystems, Carlsbad, CA) and was amplified for cytokines Ifn-γ, Il-17A and Il-10 with SYBR green mix (BioRad, Hercules, CA) by MyiQ Single-Color Real-Time PCR machine (BioRad). Expression levels of these cytokines were normalized by GAPDH and calculated by using ΔΔCt method [2^(Ctsample –Ctctrl)].
Statistical analyses were performed by GraphPad (PRISM software, La Jolla, CA). Data are presented as mean ± SEM values from two or three experiments. Unpaired Student’s t test, and ANOVAs with Bonferroni post-hoc tests were used to calculate statistical significance. Values are significantly different with P-values of *P < 0.05, **P < 0.01, and ***P < 0.001.
CD8+ T cells from VDR KO mice transfer IBD to Rag KO recipients
CD8+ T cells from WT and IL-10 KO mice did not induce colitis when transferred to Rag KO recipients and histopathology of the colons from Rag KO mice that received 106 WT or IL-10 KO CD8+ T cells were normal (Figure 1A). Conversely, Rag KO mice that received 106 VDR KO or IL-10/VDR DKO CD8+ T cells showed severe inflammation in the colon including hyperplasia and infiltration of immune cells (Figure 1A). The Rag KO mice that received CD8+ T cells from DKO mice lost a significant amount of their starting BW by 8 wks (Figure 1B). In fact the Rag KO recipients of DKO CD8+ T cells developed a fulminating form of IBD that resembled the IBD that develops in the DKO mice . Rag KO mice that received no cells (CTRL) gained weight over the 8 wk study and Rag KO mice that received WT, VDR KO and IL-10 KO CD8+ T cells maintained their BW (Figure 1B). None of the over 20 Rag KO recipients of VDR KO CD8+ T cells lost weight even though the mice had intense inflammation in both the colon and SI (data not shown and Figure 1A). The colon showed the greatest degree of inflammation following transfer of VDR KO CD8+ T cells to Rag KO recipients.
In order to determine what the differences were between VDR KO and WT CD8+ T cells, the CD8+ T cells were characterized from WT and VDR KO mice. There was a higher frequency of naïve (CD62Lhigh/CD44low) and CD8/CD28− cells and a lower frequency of activated (CD62Llow/CD44high) and CD8/CD122+ cells in the spleen of VDR KO compared to WT mice (Figure 1C). CD25+ expression on CD8+ T cells was low and less than 2% of the CD8+ T cells in VDR KO and WT mice expressed CD25 (Additional file 1: Figure S1C). In addition, there was no difference between expression of CD25 on VDR KO and WT CD8+ T cells (Additional file 1: Figure S1C). There was no difference in the total number of splenocytes isolated from WT and VDR KO mice and therefore changes in frequency also resulted in changes in absolute numbers of cells. The frequency of granzyme B+ cells was not different in CD3/CD28 activated VDR KO and WT CD8+ T cells (data not shown). IL-17 and IL-10 were undetectable while IFN-γ was not different in the supernatants from CD3/CD28 activated VDR KO and WT CD8+ T cells (data not shown). The finding of more regulatory CD8/CD28− and less regulatory CD8/CD122+ from the VDR KO mice was followed up by doing additional transfers to Rag KO mice using purified populations of these regulatory cell types.
Rag KO recipients of 106 sorted WT CD8/CD28− or CD8/CD28+ T cells weighed the same as the CTRL Rag KO mice that did not receive any cells (Figure 1D). Conversely, Rag KO recipients of 106 sorted VDR KO CD8/CD28− or CD8/CD28+ T cells lost significantly more weight than the CTRL and WT CD8 T cell recipients (Figure 1D). Sorted 106 CD8/CD122+ T cell transfers from either WT or VDR KO mice did not induce weight loss or colitis in Rag KO recipients (data not shown). Histopathology of colonic tissue from Rag KO recipients of VDR KO CD8+ subsets (CD28+/−) showed significantly more inflammation and epithelial hyperplasia than CTRL (Figure 1E). Histopathology of colonic tissue from Rag KO recipients of WT CD8+ subsets (CD28+/−) was not different from CTRL (Figure 1E). Increased colitis in Rag KO recipients of VDR KO CD8+ T cells is not a result of a difference in the CD28+/− subpopulations.
VDR KO CD8+ T cells accelerate CD4/CD45RBhigh cell-mediated colitis
The effect of CD8+ T cells on CD4/CD45RBhigh (naïve CD4+) T cell induced colitis in Rag KO recipients was examined. Rag KO mice were injected with 106 sorted CD8+ T cells from CD45.2+ VDR KO or CD45.2+ WT mice. The next day, the same Rag KO mice were injected with sorted 4 × 105 WT naïve CD45.1+/CD4 T cells to induce colitis. Rag KO recipients of only naïve CD4 T cells (CD4 only) lost 10% of their original BW, and weighed significantly less than the CTRL mice at 7 wks post-transfer (Figure 2A). Weight loss in the Rag KO recipients of naïve WT CD4 cells plus WT CD8 T cells (CD4 + WTCD8) was no different from the recipients of CD4 only T cells (Figure 2A). Rag KO recipients of naïve WT CD4 plus VDR KO CD8 T cells (CD4 + KOCD8) lost 20% of their original BW, which was significantly more weight loss than any other group (Figure 2A). The colon/BW% was lowest in the CTRL, intermediate in the CD4 only and CD4 + WTCD8 groups and highest in the CD4 + KOCD8 group (Figure 2B). The histopathology scores from Rag KO recipients of CD4 + KOCD8 T cells were 6.5 ± 0.4, which was significantly higher than the scores for all other groups (Figure 2C and data not shown). CD8+ T cells from VDR KO mice produced twice as much IFN-γ and IL-17A than WT CD8+ T in the IEL of Rag KO recipients (Figure 2D). In addition, the Rag KO recipients of CD4 + KOCD8 T cells had significantly more total IFN-γ and IL-17A producing cells in the IEL than recipients of CD4 + WTCD8 T cells (Figure 2E). The same mice from Figure 2 were used to measure the expression of Il-17A and Ifn-γ mRNA (Additional file 3: Figure S3). Il-17A and Ifn-γ mRNA expression was higher in both the SI and colon of the Rag KO recipients of CD4 + KOCD8 T cells than the Rag KO recipients of CD4 + WTCD8 T cells (Additional file 3: Figure S3). Rag KO recipients of CD8+ T cells from VDR KO mice had more IFN-γ and IL-17A in the SI and colon that corresponded to the increased severity of naïve CD4+ T cell induced colitis.
Increased CD8+, but reduced naive CD4+ T cells in VDR KO cell recipients
The MLN and IEL of the SI were used to determine the origin of T cells in the gastrointestinal tract of the Rag KO recipients. The MLN and IEL were used since these tissues normally have high frequencies of T cells and can demonstrate the extent of immune reconstitution of Rag KO mice following T cell transfer. 70 ± 5% of the IEL in Rag KO recipients of only CD4 cells were the donor CD4/CD45.1+ T cells (Figure 3A). The remaining cells in the IEL (30%) were the resident Rag KO IEL cells (innate immune cells) that did not express CD45.1 or CD8β. In the Rag KO recipients of CD4 + WTCD8 cells, 36 ± 5% of the IEL were CD4+ cells (CD45.1+) and 33 ± 4% were CD8αβ (CD8β+/CD45.1−) T cells such that together 69% of the IEL in the recipient were T cells (Figure 3A). The Rag KO recipients of the CD4 + KOCD8 cells had fewer CD4+ cells (8 ± 1%) and more CD8αβ cells (64 ± 5%) than the other groups of mice (72% total T cells, Figure 3A). The reconstitution of the MLN mirrored the IEL in that the recipients of CD4 + WTCD8 cells had approximately equal representation of CD4 and CD8αβ cells in the MLN while the mice that received CD4 + KOCD8 cells had significantly more CD8+ than CD4+ T cells in the MLN (Figure 3B). There were no differences in the total frequency of CD8αα+ expressing T cells (18-21% of the T cells) in the IEL of the Rag KO recipients of CD4 + WTCD8 or CD4 + KOCD8 T cells (Figure 3C). Significantly more CD8+ T cells were recovered in the MLN and IEL of CD4 + KOCD8 than CD4 + WTCD8 T cell transferred Rag KO recipient mice.
Increased proliferation of VDR KO CD8+ T cells in vivo
Based on the finding of increased numbers (Figure 3) of VDR KO CD8 cells in the IEL and MLN following co-transfer to Rag KO mice; additional experiments were done to determine whether VDR KO CD8 T cells proliferate more rapidly than WT CD8 T cells. Sorted CD8+ T cells were detectable in the MLN of Rag KO recipients on d3 following transfer (Figure 4A). Conversely, there were no T cells found in the IEL after 3 days (Figure 4A). At d3 in the MLN most of the CD8+ T cells from either WT or VDR KO donors were undergoing division (88 ± 2% incorporated BrdU). There were two distinct populations of BrdU+ cells in the MLN; one with low-mean fluorescence intensity (MFI, few rounds of proliferation) and the other one with high-MFI (Figure 4A, multiple rounds of proliferation). 61 ± 3% of VDR KO CD8+ T cells were of the BrdU high-MFI phenotype and only 41 ± 2% of the WT CD8+ T cells were BrdU high-MFI (Figure 4A). On d8 there were also more high-MFI profile VDR KO CD8+ T cells (51 ± 4%) than WT CD8+ T cells (39 ± 2%, Figure 4A). By day 14 in the MLN there was a small population (16 ± 3%) of BrdU very high-MFI VDR KO CD8+ T cells and significantly less of these cells in the WT CD8+ T recipients (4 ± 1%, Figure 4A). CD8+ T cells appeared in the IEL on d8 (Figure 4A). Significantly fewer cells were BrdU high-MFI in the IEL of Rag KO recipients of WT CD8+ T cells (8 ± 3%) than VDR KO CD8+ T cells (22 ± 2%, Figure 4A). There were also two distinct peaks of BrdU incorporation evident at d14 in the IEL samples and again the high-MFI peak was over represented in the recipients of VDR KO CD8+ T cells (Figure 4A). Total VDR KO CD8+ T cells were proliferating faster than WT CD8+ T cells in vivo.
To identify which T cell subsets were undergoing rapid proliferation in the Rag KO recipients, the BrdU MFI-high cells from Figure 4A were phenotyped. Naïve CD8+ T cells (CD62LhighCD44low) from VDR KO mice proliferated more than their WT counterparts in the MLN and IEL on d3 and d8 post-transfer (Figure 4B). Conversely, activated CD8+ T cells (CD62LlowCD44high) from VDR KO mice proliferated at the same rate (differences were not significant) as activated cells from WT mice post-transfer (Figure 4B). More naïve VDR KO CD8+ T cells than naïve WT CD8+ T cells were proliferating rapidly in vivo.
Increased proliferation of VDR KO CD8+ T cells in vitro
Proliferation of the CD8+ T cells from VDR KO and WT mice was also tested in vitro. Even though there was very little proliferation detected in the CD3/CD28 stimulated cultures at d1, VDR KO CD8+ T cells had 2.4 ± 0.2% of the cells proliferating while none of the WT CD8+ T cells were proliferating (Figure 5A). On d2 there were two rounds of proliferation evident in the WT CD8+ T cell cultures and three rounds of proliferation in the VDR KO CD8+ T cell cultures (Figure 5A). In addition, there were significantly more VDR KO CD8+ T cells proliferating (64 ± 3%) compared to WT CD8+ T cells (51 ± 2%) at d2. By d3 almost all of the cells in both cultures had proliferated and there were no longer significant differences in the frequency of CD8+ T cells that had undergone proliferation (Figure 5A). VDR KO CD8+ T cells were proliferating faster than WT CD8+ T cells in vitro.
The CFSE stained cells in panel A were also stained to look at naïve and activated cells in the cultures. On day 2 significantly more of the naïve (CD62LhighCD44low) CD8+ T cells from VDR KO mice had proliferated in response to CD3/CD28 stimulation than WT (Figure 5B). By day 3 the naive VDR KO CD8+ T cells were proliferating rapidly in the presence and absence of CD3/CD28 stimulation while the naïve WT CD8+ T cells were not (Figure 5B). The naïve VDR KO CD8+ cells were dividing but not downregulating CD62L and upregulating CD44 (Figure 5B). CD8+ T cells with an activated phenotype (CD62LlowCD44high) proliferated strongly in both the WT and VDR KO cultures at both d2 and d3 post-stimulation and there were no differences between the proliferation of the activated VDR KO and WT CD8+ T cells (Figure 5B). Phenotypically naïve VDR KO CD8+ T cells proliferated with or without stimulation but did not express activation markers as a result of proliferation.
VDR KO CD8+ T cells over-produce and respond to IL-2 robustly
The role of IL-2 in the increased proliferation of VDR KO CD8+ T cells was determined. CD25 expression was not different on VDR KO and WT CD8+ T cells (Additional file 1: Figure S1D). 3 days of culture were required in order to detect proliferation of CD8+ T cells in response to IL-2 (d2 data not shown, Figure 6A). 24 ± 3% of WT CD8 T cells and 50 ± 4% of VDR KO CD8+ T cells divided at d3 following addition of IL-2 (Figure 6A). Addition of IL-2 plus IL-2 neutralizing antibodies prevented all of the WT CD8+ T cell proliferation while VDR KO CD8+ T cells still had 6 ± 2% undergoing proliferation in the presence of neutralizing antibodies to IL-2 (Figure 6A). The supernatants from CD8+ T cells cultures stimulated with CD3 and CD28 antibodies were evaluated for the production of IL-2. Unstimulated VDR KO and WT CD8+ T cells did not produce detectable IL-2 after 3 days in culture (Figure 6B). CD3/CD28 stimulated VDR KO CD8+ T cells produced 2-fold more IL-2 than WT CD8+ T cells (Figure 6B). Overproduction of IL-2 contributes to the more rapid proliferation of CD3/CD28 activated VDR KO CD8+ T cells.
VDR KO CD8+ T cells proliferated more rapidly both in vitro and in vivo. The increased rate of proliferation following activation was associated with the over production of IL-2 from the CD8+ T cells themselves. The rapidly proliferating naïve donor VDR KO CD8+ T cells found residence in the MLN first and then in the IEL of the Rag KO mice where they out-competed the CD4+ T cells and contributed to colitis development by inducing IL-17A and IFN-γ production. In Rag KO recipients of WT CD8+ T cells endogenously produced 1,25(OH)2D3 slowed down the proliferation of the T cells, while the VDR KO CD8+ T cells could not respond to 1,25(OH)2D3. The 1,25(OH)2D3 also acted on WT CD8+ T cells to inhibit IL-17 and IFN- γ responses. In VDR KO mice the CD8+ T cells with a naïve phenotype were over-represented but their proliferation must have been controlled since VDR KO mice did not develop overt colitis symptoms . VDR KO mice had normal FoxP3+ T regulatory cells that may have prevented the naïve CD8+ T cells from expanding and causing colitis . Naïve CD8+ VDR KO T cells divided in vitro even in the absence of stimulation (Figure 5B). This is unique to the VDR KO CD8+ T cells, since naïve CD4+ VDR KO T cells proliferated at the same rate as naïve CD4+ WT T cells (unpublished data and ). Proliferation was not associated with upregulation of activation markers since the proliferating CD8+ T cells were still CD62Lhigh/CD44low. VDR expression must be required for the quiescence of naïve CD8+ T cells.
Naïve and memory CD8+ T cells use different cytokines to regulate proliferation . The proliferation of naïve T cells requires IL-7 receptor (R) α, but not IL-15; conversely, memory T cells use either IL-7Rα or IL-15 for proliferation . It would be difficult to envision how this differential use of IL-7 versus IL-15 could account for the increased proliferation of predominately naïve CD8+ T cells. Instead it may be that developmentally the VDR is required to control the proliferation rate of the naïve CD8+ T cells but not the differentiated effector or memory cells. Somewhat surprisingly CD8+ T cells from VDR KO mice produced the same amounts of granzyme B and IFN-γ as WT CD8+ T cells (data not shown). Instead, CD8+ T cells from VDR KO mice overproduced IL-2 that may act in a paracrine manner on the CD8+ T cells themselves.
The original function of 1,25(OH)2D3 in the immune system was shown to be as a suppressor of mitogen induced proliferation . Those early studies established that 1,25(OH)2D3 suppressed T cell proliferation in both CD4+ and CD8+ by blocking transition of the cycling cells from early G1 to late G1 [29, 30]. In addition, IL-2 was shown to be a target of 1,25(OH)2D3 treatments and 1,25(OH)2D3 inhibited production of IL-2 . The inhibition of IL-2 expression was due to the direct interaction of the VDR/1,25(OH)2D3 complex that blocked the binding of the NFATp/AP1 complex to the IL-2 promoter . The effects of 1,25(OH)2D3 on IL-2 contributed to the suppression of T cell proliferation by 1,25(OH)2D3 but proliferation of 1,25(OH)2D3 treated T cells was only partially reversed by exogenous IL-2 addition . Administration of exogenous IL-2 can increase the frequency of CD8+ memory cells [33, 34]. Autocrine IL-2 secretion by memory CD8+ T cells has been shown to be a critical mechanism to maintain the CD8+ T cells . The data in the VDR KO CD8+ T cells suggest that the VDR must participate as a negative co-regulator of proliferation and IL-2 production in CD8+ T cells. The data further suggest that expression of the VDR may be important in regulation of the memory CD8+ response.
Vitamin D serves as a regulator of proliferation across many different cell types. In addition to inhibiting the proliferation of T cells, 1,25(OH)2D3 inhibits the proliferation of keratinocytes, B cells, epithelial cells and several different types of cancer cells [36, 37]. Topical 1,25(OH)2D3 inhibits proliferation and induces resolution of psoriasis . In addition, vitamin D deficiency is associated with an increase in several different types of cancer . VDR KO mice have increased epithelial cell proliferation in the gastrointestinal tract and skin . More recently we have shown that in the immune system control of homeostatic proliferation and apoptosis underlie the basic mechanisms whereby vitamin D regulates TCRαβ/CD8αα and iNKT cell numbers [9, 39]. Vitamin D and the VDR seem to be master regulators of proliferation across many cell types. In CD8+ T cells there is a selective requirement for VDR signaling to control the numbers of naïve CD8+ T cells in the periphery.
VDR KO CD8+ T cells induce colitis in the Rag KO recipients. However, the Rag KO recipients of VDR KO CD8+ T cells did not lose weight or develop overt symptoms of experimental IBD, suggesting that there must be some regulatory cell or cytokine being produced to limit the pathogenicity of the cells. There did not appear to be any CD28− or CD122+ regulatory cell in the VDR KO CD8+ T cells. Confirming the literature the Rag KO recipients of IL-10 KO CD8+ T cells did not induce colitis . However, IL-10/VDR DKO CD8+ T cells induced a fulminating form of IBD including rectal bleeding, and significant weight loss. Therefore it seems that autocrine IL-10 production by CD8+ T cells prevents overt colitis induced by VDR KO CD8+ T cells.
The VDR is critical for controlling the rate of proliferation of naïve CD8+ T cells and the ability of the CD8+ T cells to both produce and respond to IL-2. In the absence of vitamin D signaling rapidly proliferating CD8+ T cells accumulate in the gut and contribute to the production of IL-17 and IFN-γ. Autocrine production of IL-10 limits VDR KO CD8+ T cell- induced colitis. In the T cell transfer model of IBD other regulatory cells are absent that might inhibit the proliferation of the VDR KO CD8+ T cells to control inflammation in the gastrointestinal tract. Expression of the VDR halts the nonspecific expansion of the naïve CD8+ T cells. Vitamin D control of the CD8+ T cell response contributes to the maintenance of gastrointestinal homeostasis.
In summary, VDR-deficiency results in the generation of pathogenic CD8+ T cells that contributes to the development of IBD. The causes of the VDR KO CD8+ T cell induced IBD was the rapid proliferation of CD8+ T cells in general and naïve CD8+ T cells in particular, and the overproduction and response to IL-2. Expression of the VDR prevents homeostatic proliferation of CD8+ T cells and vitamin D through the VDR maintains gastrointestinal homeostasis.
Inflammatory bowel disease
Mean fluorescence intensity
Vitamin D receptor
Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB: Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host and Microbe. 2007, 2: 119-129. 10.1016/j.chom.2007.06.010.
Webb AR, Pilbeam C, Hanafin N, Holick MF: An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr. 1990, 51 (6): 1075-1081.
Ardizzone S, Cassinotti A, Bevilacqua M, Clerici M, Porro GB: Vitamin D and inflammatory bowel disease. Vitam Horm. 2011, 86: 367-377.
Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ: Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics. 2006, 118 (5): 1950-1961. 10.1542/peds.2006-0841.
Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT: A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003, 17 (12): 2386-2392. 10.1210/me.2003-0281.
Cantorna MT: Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch Biochem Biophys. 2012, 523 (1): 103-106. 10.1016/j.abb.2011.11.001.
Zella JB, McCary LC, DeLuca HF: Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003, 417 (1): 77-80. 10.1016/S0003-9861(03)00338-2.
Froicu M, Zhu Y, Cantorna MT: Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology. 2006, 117 (3): 310-318. 10.1111/j.1365-2567.2005.02290.x.
Bruce D, Cantorna MT: Intrinsic requirement for the vitamin D receptor in the development of CD8alphaalpha-expressing T cells. J Immunol. 2011, 186 (5): 2819-2825. 10.4049/jimmunol.1003444.
Bruce D, Yu S, Ooi JH, Cantorna MT: Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int Immunol. 2011, 23 (8): 519-528. 10.1093/intimm/dxr045.
Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE: 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur J Immunol. 2011, 41 (3): 822-832. 10.1002/eji.201040632.
Mahon BD, Wittke A, Weaver V, Cantorna MT: The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003, 89 (5): 922-932. 10.1002/jcb.10580.
Thien R, Baier K, Pietschmann P, Peterlik M, Willheim M: Interactions of 1 alpha,25-dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes. J Allergy Clin Immunol. 2005, 116 (3): 683-689. 10.1016/j.jaci.2005.05.013.
Yu S, Cantorna MT: The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA. 2008, 105 (13): 5207-5212. 10.1073/pnas.0711558105.
Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002, 195 (5): 603-616. 10.1084/jem.20011629.
Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L: A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002, 51 (5): 1367-1374. 10.2337/diabetes.51.5.1367.
Veldman CM, Cantorna MT, DeLuca HF: Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000, 374 (2): 334-338. 10.1006/abbi.1999.1605.
Steinhoff U, Brinkmann V, Klemm U, Aichele P, Seiler P, Brandt U, Bland PW, Prinz I, Zugel U, Kaufmann SHE: Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity. 1999, 11 (3): 349-358. 10.1016/S1074-7613(00)80110-7.
Wiesel M, Oxenius A: From crucial to negligible: functional CD8(+) T-cell responses and their dependence on CD4(+) T-cell help. Eur J Immunol. 2012, 42 (5): 1080-1088. 10.1002/eji.201142205.
Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M: Nonantigen specific CD8(+) T suppressor lymphocytes originate from CD8(+)CD28(-) T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol. 2004, 65 (2): 142-156. 10.1016/j.humimm.2003.12.001.
Menager-Marcq I, Pomie C, Romagnoli P, van Meerwijk JPM: CD8(+)CD28(-) regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology. 2006, 131 (6): 1775-1785. 10.1053/j.gastro.2006.09.008.
Shi Z, Okuno Y, Rifa’i M, Endharti AT, Akane K, Isobe KI, Suzuki H: Human CD8(+) CXCR3(+) T cells have the same function as murine CD8(+) CD122(+) Treg. Eur J Immunol. 2009, 39 (8): 2106-2119. 10.1002/eji.200939314.
Endharti AT, Okuno Y, Shi Z, Misawa N, Toyokuni S, Ito M, Isobe K, Suzuki H: CD8(+)CD122(+) Regulatory T Cells (Tregs) and CD4(+) Tregs Cooperatively Prevent and Cure CD4(+) Cell-Induced Colitis. J Immunol. 2011, 186 (1): 41-52. 10.4049/jimmunol.1000800.
Poussier P, Ning T, Banerjee D, Julius M: A unique subset of self-specific intraintestinal T cells maintains gut integrity. J Exp Med. 2002, 195 (11): 1491-1497. 10.1084/jem.20011793.
Das G, Augustine MM, Das J, Bottomly K, Ray P, Ray A: An important regulatory role for CD4 + CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci USA. 2003, 100 (9): 5324-5329. 10.1073/pnas.0831037100.
Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT: Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA. 2008, 105 (52): 20834-20839. 10.1073/pnas.0808700106.
Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, Benoist C, Mathis D, Butz EA: Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8(+) T cells. J Exp Med. 2002, 195 (12): 1515-1522. 10.1084/jem.20020033.
Tsoukas CD, Provvedini DM, Manolagas SC: 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984, 224 (4656): 1438-1440. 10.1126/science.6427926.
Rigby WF, Noelle RJ, Krause K, Fanger MW: The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol. 1985, 135 (4): 2279-2286.
Rigby WF, Yirinec B, Oldershaw RL, Fanger MW: Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol. 1987, 17 (4): 563-566. 10.1002/eji.1830170420.
Rigby WF, Stacy T, Fanger MW: Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest. 1984, 74 (4): 1451-1455. 10.1172/JCI111557.
Alroy I, Towers TL, Freedman LP: Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol. 1995, 15 (10): 5789-5799.
Boyman O, Kovar M, Rubinstein MP, Surh CD, Sprent J: Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 2006, 311 (5769): 1924-1927. 10.1126/science.1122927.
Blattman JN, Grayson JM, Wherry EJ, Kaech SM, Smith KA, Ahmed R: Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med. 2003, 9 (5): 540-547. 10.1038/nm866.
Feau S, Arens R, Togher S, Schoenberger SP: Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol. 2011, 12 (9): 908-913. 10.1038/ni.2079.
Lemire JM, Adams JS, Sakai R, Jordan SC: 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest. 1984, 74 (2): 657-661. 10.1172/JCI111465.
Carlberg C, Molnar F: Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012, 12 (6): 528-547. 10.2174/156802612799436623.
Welsh J: Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys. 2012, 523 (1): 107-114. 10.1016/j.abb.2011.10.019.
Yu S, Cantorna MT: Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol. 2011, 186 (3): 1384-1390. 10.4049/jimmunol.1002545.
Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM: T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med. 1996, 184 (1): 241-251. 10.1084/jem.184.1.241.
We thank Dr. Marie Demay (Harvard University, Boston MA) for providing the original VDR KO breeders. We also thank Animal Diagnostic Lab and Cytometry Facility (The Pennsylvania State University, University Park PA) for technical assistance. This work was supported in part by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [DK070781]; National Institutes of Neurologic and Stroke Grant [NS067563] and National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements [AT005378].
The authors declare that they have no competing interests.
JC, DB and MTC designed the research; JC and DB conducted the research; JC, DB and MTC analyzed the research; JC and MTC wrote the manuscript. MTC had primary responsibility for final content. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 2: Figure S2: (A) Forward and side scatter of splenic lymphocytes. CD8β+ cells were gated on and stained for CD28, CD122 and isotype controls. (B) Forward and side scatter for the IEL and MLN. (C) Sorted CD8 cells were cultured without stimulation or with CD3/CD28 for 3 days and stained for CD8β, CD44 and CD62L antibodies. CFSE staining was analyzed in the CD44low/CD62Lhigh (naive) and CD44high/CD62Llow (activated) populations. (PDF 299 KB)
Authors’ original submitted files for images
About this article
Cite this article
Chen, J., Bruce, D. & Cantorna, M.T. Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol 15, 6 (2014). https://doi.org/10.1186/1471-2172-15-6
- Vitamin D receptor
- CD8+ T cells
- Inflammatory bowel disease